Why the study?
Recent reports raised concerns regarding an association between mRNA-based SARS-CoV-2 vaccines and acute myocarditis, predominantly among male adolescents and young adults following the second dose.
The review highlights the association of mRNA COVID-19 vaccines with acute myocarditis in young males and advocates for precision vaccinology to improve vaccine safety.
Answers are grounded in this paper and cite their sources.
Warrants heightened clinical vigilance for myocarditis in young males post-vaccination; leaves open the.
Systems vaccinology approaches have introduced novel tools for the evaluation of the safety profile of novel vaccine antigens by developing biomarkers of vaccine reactogenicity associated with potential adverse events. The use of such approaches may prove extremely advantageous in the context of a global pandemic where accelerated approval of new vaccine formulations for all ages is essential for the containment of the epidemic. The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had devastating effects on global health, but the emergency authorization of mRNA vaccines significantly reduced SARS-CoV-2-associated morbidity and mortality. Despite their favorable safety profile in adult populations, recent reports have raised concerns about an association of the mRNA-based vaccines with acute myocarditis, predominantly among male adolescents and young adults following the second vaccine dose. Here, we review data on myocarditis epidemiology following SARS-CoV-2 mRNA vaccination and describe potential mechanisms involved that may explain the sex- and age-related differences, focusing on mRNA immune reactivity. The case of vaccine-associated myocarditis highlights the need to incorporate precision vaccinology approaches for the development of safe and effective vaccines for everyone.
No takes yet. Share an insight, caveat, or question.
Lagousi et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: